Biomarkers of intestinal permeability are associated with inflammation in metabolically healthy obesity but not normal-weight obesity

被引:0
|
作者
Keirns, Bryant H. [1 ]
Medlin, Austin R. [2 ]
Maki, Katherine A. [3 ]
McClanahan, Kristen [4 ]
Fruit, Sarah E. [1 ]
Sciarrillo, Christina M. [4 ]
Hart, Samantha M. [4 ]
Joyce, Jill [4 ]
Lucas, Edralin A. [4 ]
Emerson, Sam R. [4 ]
机构
[1] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA
[2] Indiana Univ, Sch Publ Hlth, Dept Hlth & Wellness Design, Bloomington, IN USA
[3] NIH, Translat Biobehav & Hlth Dispar Branch, Clin Ctr, Bethesda, MD USA
[4] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2024年 / 327卷 / 05期
关键词
cardiovascular disease; gut permeability; inflammation; metabolically healthy obesity; normal-weight obesity; INSULIN-RESISTANCE; OXIDATIVE STRESS; GUT PERMEABILITY; EATING INDEX; SERUM-LEVELS; INDIVIDUALS; MARKERS; ENDOTOXEMIA; DYSFUNCTION; MORTALITY;
D O I
10.1152/ajpheart.00381.2024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic inflammation is reported in normal-weight obesity (NWO) and metabolically healthy obesity (MHO), which may be linked to their increased cardiovascular disease (CVD) risk. Yet, drivers of this inflammation remain unclear. We characterized factors known to influence inflammatory status (i.e., intestinal permeability, adipose tissue, diet quality, microbiota), and their relationships with measured inflammation, in NWO and MHO, healthy control subjects (CON), and metabolically unhealthy obesity (MUO; N = 80; n = 20/group). Serum indicators of intestinal permeability and inflammation were assessed by ELISA and/or multiplex. Total, visceral, and percent body fat were measured with dual-energy X-ray absorptiometry (DXA). Fecal microbiota composition was assessed via 16S rRNA sequencing (n = 9-10/group). For C-reactive protein (CRP), MUO > NWO > CON (P < 0.0001). In MHO, CRP was intermediate and similar to both MUO and NWO. Lipopolysaccharide binding protein (LBP) and the ratio of LBP to soluble CD14 (sCD14) were higher in MHO and MUO vs. CON/NWO (P < 0.0001). Across correlation and regression analyses, LBP consistently displayed the strongest relationships with CRP in the entire sample (r = 0.78; beta = 0.57; P < 0.0001) and in MHO (r = 0.74; P < 0.01) but not NWO (r = 0.37; P = 0.11). Shannon index was higher in CON compared with MUO (P < 0.05) and inversely correlated with CRP in the full sample (r = -0.37; P < 0.05). These data are consistent with the notion that intestinal permeability is associated with low-grade inflammation in MHO, which could be implicated in this population's reported CVD risk. NEW & NOTEWORTHY This is the first study to our knowledge to examine biomarkers of intestinal permeability in normal-weight obesity and one of few assessing microbiota compositions in this population. Additionally, we report that individuals with metabolically healthy obesity and metabolically unhealthy obesity displayed similar evidence of intestinal permeability, which was more strongly associated with systemic inflammation than total and visceral adipose tissue mass.
引用
收藏
页码:H1135 / H1145
页数:11
相关论文
共 50 条
  • [21] Are Women with Normal-Weight Obesity at Higher Risk for Cardiometabolic Disorders?
    Ashtary-Larky, Damoon
    Niknam, Sara
    Alipour, Meysam
    Bagheri, Reza
    Asbaghi, Omid
    Mohammadian, Mehrnaz
    Jaime, Salvador J.
    Baker, Julien S.
    Wong, Alexei
    Suzuki, Katsuhiko
    Afrisham, Reza
    BIOMEDICINES, 2023, 11 (02)
  • [22] Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents
    Ding, W. Q.
    Yan, Y. K.
    Zhang, M. X.
    Cheng, H.
    Zhao, X. Y.
    Hou, D. Q.
    Mi, J.
    JOURNAL OF HUMAN HYPERTENSION, 2015, 29 (09) : 548 - 554
  • [23] Metabolically healthy obesity and unhealthy normal weight rural adults in Xinjiang: prevalence and the associated factors
    Wang, Wen-qiang
    Wei, Bin
    Song, Yan-peng
    Guo, Heng
    Zhang, Xiang-hui
    Wang, Xin-ping
    Yan, Yi-zhong
    Ma, Jiao-long
    Wang, Kui
    Keerman, Mulatibieke
    Zhang, Jing-yu
    Ma, Ru-lin
    Guo, Shu-xia
    He, Jia
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [24] Metabolically healthy obesity: prevalence, phenotype characteristic, effectiveness of weight loss
    Ostrovskaya, Elena, V
    Romantsova, Tatiana, I
    Gerasimov, Andrei N.
    Novoselova, Tamara E.
    RUSSIAN OPEN MEDICAL JOURNAL, 2020, 9 (03)
  • [25] Is Metabolically Healthy Obesity Really Healthy for the Heart?
    Lavie, Carl J.
    Neeland, Ian J.
    JACC-CARDIOVASCULAR IMAGING, 2023, 16 (07) : 902 - 904
  • [26] Normal-weight central obesity is associated with metabolic disorders in Chinese postmenopausal women
    Liu, Peng Ju
    Ma, Fang
    Lou, Hui Ping
    Zhu, Yan Ning
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2017, 26 (04) : 692 - 697
  • [27] Normal-weight central obesity: implications for diabetes mellitus
    Jin, Xueshan
    Liu, Jiajun
    Cao, Qiuyu
    Lin, Jiehua
    Wu, Guangfu
    Liu, Longhui
    Jiang, Shan
    Zhou, Xin
    Li, Zhiqiang
    Yang, Aicheng
    FRONTIERS IN NUTRITION, 2023, 10
  • [28] Emerging concepts in metabolically healthy obesity
    Duque, Alice P.
    Rodrigues, Luiz F. Junior
    Mediano, Mauro F. F.
    Tibirica, Eduardo
    De Lorenzo, Andrea
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2020, 10 (02): : 48 - 61
  • [29] Metabolically healthy obesity: a friend or foe?
    Jung, Chang Hee
    Lee, Woo Je
    Song, Kee-Ho
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (04) : 611 - 621
  • [30] Dysmetabolic signals in "metabolically healthy" obesity
    Manu, Peter
    Ionescu-Tirgoviste, Constantin
    Tsang, James
    Napolitano, Barbara A.
    Lesser, Martin L.
    Correll, Christoph U.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2012, 6 (01) : E9 - E20